# Non-Inferiority Clinical Trials - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/non-inferiority-clinical-trials/c4be9c7c-051a-4a72-8e2e-d996945a9cd9

> FDA guidance document: Non-Inferiority Clinical Trials. Issue date: November 08, 2016. Get complete insights and analysis.

---

## Details

- Title: Non-Inferiority Clinical Trials
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2016-11-08
- Last Changed: 2020-04-27
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2010-D-0075">FDA-2010-D-0075</a>

## Related Documents

- [Scientific Considerations in Demonstrating Biosimilarity to a Reference Product](https://www.globalkeysolutions.net/guidances/guidance-document/scientific-considerations-in-demonstrating-biosimilarity-to-a-reference-product/b98b0335-f4b7-4a14-88b1-7ea4d02c7e37)
- [Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/adaptive-design-clinical-trials-for-drugs-and-biologics-guidance-for-industry/97c6b6e1-4164-4fbe-8059-b0aa3fd39415)
- [Clinical Pharmacology Considerations for Antibody-Drug Conjugates  Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-antibody-drug-conjugates-guidance-for-industry-guidance-for-industry/ee3ed09c-6580-489f-bb06-0e93f612d604)